A cost-consequence analysis of parecoxib and opioids vs opioids alone for postoperative pain: Chinese perspective

Magdolna Barra,1 Edit Remák,1 Dong Dong Liu,2 Li Xie,2 Lucy Abraham,3 Alesia B Sadosky4 1Evidera, Budapest, Hungary; 2Health Economics & Outcomes Research, Pfizer Investment Co., Ltd., Beijing, China; 3Health Economics & Outcomes Research, Pfizer Ltd, Tadworth, UK; 4Health...

Full description

Bibliographic Details
Main Authors: Barra M, Remák E, Liu DD, Xie L, Abraham L, Sadosky AB
Format: Article
Language:English
Published: Dove Medical Press 2019-02-01
Series:ClinicoEconomics and Outcomes Research
Subjects:
Online Access:https://www.dovepress.com/a-cost-consequence-analysis-of-parecoxib-and-opioids-vs-opioids-alone--peer-reviewed-article-CEOR